SG11201706562QA - NON-MEMBRANE DISRUPTIVE p53 ACTIVATING STAPLED PEPTIDES - Google Patents

NON-MEMBRANE DISRUPTIVE p53 ACTIVATING STAPLED PEPTIDES

Info

Publication number
SG11201706562QA
SG11201706562QA SG11201706562QA SG11201706562QA SG11201706562QA SG 11201706562Q A SG11201706562Q A SG 11201706562QA SG 11201706562Q A SG11201706562Q A SG 11201706562QA SG 11201706562Q A SG11201706562Q A SG 11201706562QA SG 11201706562Q A SG11201706562Q A SG 11201706562QA
Authority
SG
Singapore
Prior art keywords
activating
stapled peptides
membrane disruptive
disruptive
membrane
Prior art date
Application number
SG11201706562QA
Other languages
English (en)
Inventor
Yaw Sing Tan
Christopher John Brown
Chandra S Verma
Gago Fernando Jose Ferrer
David P Lane
Thomas Joseph
Original Assignee
Agency Science Tech & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency Science Tech & Res filed Critical Agency Science Tech & Res
Publication of SG11201706562QA publication Critical patent/SG11201706562QA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10Peptides having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG11201706562QA 2015-02-13 2016-02-15 NON-MEMBRANE DISRUPTIVE p53 ACTIVATING STAPLED PEPTIDES SG11201706562QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SG10201501119W 2015-02-13
PCT/SG2016/050079 WO2016130092A1 (en) 2015-02-13 2016-02-15 Non-membrane disruptive p53 activating stapled peptides

Publications (1)

Publication Number Publication Date
SG11201706562QA true SG11201706562QA (en) 2017-09-28

Family

ID=56614951

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201706562QA SG11201706562QA (en) 2015-02-13 2016-02-15 NON-MEMBRANE DISRUPTIVE p53 ACTIVATING STAPLED PEPTIDES

Country Status (6)

Country Link
US (1) US11319344B2 (de)
EP (1) EP3256484B1 (de)
JP (1) JP7028643B2 (de)
CN (1) CN107531759B (de)
SG (1) SG11201706562QA (de)
WO (1) WO2016130092A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020027585A2 (ko) * 2018-07-31 2020-02-06 주식회사 레모넥스 폴리펩타이드 전달용 조성물
EP3838924A4 (de) * 2018-07-31 2022-06-22 Lemonex Inc. Polypeptidabgabezusammensetzung
CN111613275B (zh) * 2020-05-26 2021-03-16 中国海洋大学 一种基于rmsd多特征的药物分子动力学结果分析方法
WO2022081827A1 (en) 2020-10-14 2022-04-21 Dana-Farber Cancer Institute, Inc. Chimeric conjugates for degradation of viral and host proteins and methods of use
WO2024051616A1 (zh) * 2022-09-09 2024-03-14 湖南大学 一种多肽及其制备方法和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8343760B2 (en) * 2008-06-05 2013-01-01 University Of Maryland, Baltimore p53 activator peptides
CA2769619C (en) * 2009-08-17 2019-04-30 Roche Glycart Ag Targeted immunoconjugates
US20120328692A1 (en) * 2011-06-24 2012-12-27 University Of Maryland, Baltimore Potent d-peptide antagonists of mdm2 and mdmx for anticancer therapy
EP2904000A4 (de) * 2012-10-01 2016-04-20 Agency Science Tech & Res Peptide und verfahren zur behandlung von krebs
SG10201700952XA (en) * 2013-03-13 2017-04-27 Harvard College Stapled and stitched polypeptides and uses thereof
US20150010932A1 (en) * 2013-07-02 2015-01-08 Salk Institute For Biological Studies Methods for assaying protein-protein interactions

Also Published As

Publication number Publication date
JP7028643B2 (ja) 2022-03-02
CN107531759A (zh) 2018-01-02
EP3256484B1 (de) 2021-06-23
US11319344B2 (en) 2022-05-03
CN107531759B (zh) 2021-11-16
JP2018507689A (ja) 2018-03-22
US20180030090A1 (en) 2018-02-01
EP3256484A1 (de) 2017-12-20
EP3256484A4 (de) 2018-07-25
WO2016130092A1 (en) 2016-08-18

Similar Documents

Publication Publication Date Title
PL3289985T3 (pl) Stapler chirurgiczny
EP3347035A4 (de) Auf knorpel abzielende peptide
IL275298A (en) Mitochondria-targeted peptides
EP3270945A4 (de) Selektive mcl-1-bindende peptide
SG11201706562QA (en) NON-MEMBRANE DISRUPTIVE p53 ACTIVATING STAPLED PEPTIDES
IL263292A (en) Protease-resistant mono-lipidated peptides
GB201607534D0 (en) Peptides
GB201520536D0 (en) Peptides
GB201604468D0 (en) Peptides
GB201520546D0 (en) Peptides
EP3271383A4 (de) Geheftete peptide und verwendungen davon
GB201520541D0 (en) Peptides
GB201520543D0 (en) Peptides
GB201520539D0 (en) Peptides
HK1253854A1 (zh) 抗微生物融合肽
EP3464377A4 (de) Aus dsg2 gewonnene peptide
GB201607535D0 (en) Peptides
GB201520548D0 (en) Peptides
GB201520542D0 (en) Peptides
GB201520557D0 (en) Peptides
GB201620963D0 (en) Antimicrobial peptides
EP3330045A4 (de) Klammervorrichtung
IL266419A (en) Binding peptides
GB201715378D0 (en) Peptides
GB201715379D0 (en) Peptides